Technical Analysis for AST - Asterias Biotherapeutics, Inc.

Grade Last Price % Change Price Change
grade F 0.74 -2.25% -0.02
AST closed down 2.25 percent on Friday, January 18, 2019, on 45 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical AST trend table...

Date Alert Name Type % Chg
Jan 18 Inside Day Range Contraction 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Wide Bands Range Expansion -2.25%
Jan 16 Shooting Star Candlestick Bearish -1.33%
Jan 16 Lizard Bearish Bearish Day Trade Setup -1.33%
Jan 16 Doji - Bearish? Reversal -1.33%
Jan 16 Wide Bands Range Expansion -1.33%
Jan 16 Upper Bollinger Band Touch Strength -1.33%
Jan 15 Doji - Bullish? Reversal -1.33%
Jan 15 Wide Bands Range Expansion -1.33%

Older signals for AST ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Asterias Biotherapeutics, Inc., a development stage biotechnology company, focuses on the development of therapeutic products to treat neurology, oncology, cardiology, metabolic diseases, ophthalmology, orthopedics, and blood and vascular diseases. It is also developing human embryonic stem cell programs, including cell lines and a Phase I clinical trial in patients with acute spinal cord injury; intellectual property related to its autologous cellular immunotherapy program, including a Phase I/II clinical trial of autologous immunotherapy in patients with acute myelogenous leukemia; and non-therapeutic applications of pluripotent stem cells, such as cellular assay products for use in drug development and toxicity screening. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is based in Menlo Park, California.
Is AST a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.45
52 Week Low 0.51
Average Volume 230,947
200-Day Moving Average 1.3318
50-Day Moving Average 0.9332
20-Day Moving Average 0.7024
10-Day Moving Average 0.7657
Average True Range 0.1056
ADX 20.99
+DI 15.8589
-DI 14.8301
Chandelier Exit (Long, 3 ATRs ) 0.5332
Chandelier Exit (Short, 3 ATRs ) 0.8268
Upper Bollinger Band 0.8594
Lower Bollinger Band 0.5454
Percent B (%b) 0.62
BandWidth 44.703872
MACD Line -0.0343
MACD Signal Line -0.0547
MACD Histogram 0.0204
Fundamentals Value
Market Cap 36.98 Million
Num Shares 50 Million
EPS -0.75
Price-to-Earnings (P/E) Ratio -0.99
Price-to-Sales 20.30
Price-to-Book 3.37
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.88
Resistance 3 (R3) 0.89 0.85 0.85
Resistance 2 (R2) 0.85 0.82 0.85 0.84
Resistance 1 (R1) 0.80 0.80 0.78 0.79 0.84
Pivot Point 0.76 0.76 0.76 0.76 0.76
Support 1 (S1) 0.71 0.73 0.69 0.70 0.64
Support 2 (S2) 0.67 0.71 0.67 0.64
Support 3 (S3) 0.62 0.67 0.63
Support 4 (S4) 0.61